Literature DB >> 35469069

Swarm learning for decentralized artificial intelligence in cancer histopathology.

Oliver Lester Saldanha1, Philip Quirke2, Nicholas P West2, Jacqueline A James3,4,5, Maurice B Loughrey5,6,7, Heike I Grabsch2,8, Manuel Salto-Tellez3,4,5, Elizabeth Alwers9, Didem Cifci1, Narmin Ghaffari Laleh1, Tobias Seibel1, Richard Gray10, Gordon G A Hutchins2, Hermann Brenner9,11,12, Marko van Treeck1, Tanwei Yuan9, Titus J Brinker13, Jenny Chang-Claude14,15, Firas Khader16, Andreas Schuppert17, Tom Luedde18, Christian Trautwein1, Hannah Sophie Muti1, Sebastian Foersch19, Michael Hoffmeister9, Daniel Truhn16, Jakob Nikolas Kather20,21,22.   

Abstract

Artificial intelligence (AI) can predict the presence of molecular alterations directly from routine histopathology slides. However, training robust AI systems requires large datasets for which data collection faces practical, ethical and legal obstacles. These obstacles could be overcome with swarm learning (SL), in which partners jointly train AI models while avoiding data transfer and monopolistic data governance. Here, we demonstrate the successful use of SL in large, multicentric datasets of gigapixel histopathology images from over 5,000 patients. We show that AI models trained using SL can predict BRAF mutational status and microsatellite instability directly from hematoxylin and eosin (H&E)-stained pathology slides of colorectal cancer. We trained AI models on three patient cohorts from Northern Ireland, Germany and the United States, and validated the prediction performance in two independent datasets from the United Kingdom. Our data show that SL-trained AI models outperform most locally trained models, and perform on par with models that are trained on the merged datasets. In addition, we show that SL-based AI models are data efficient. In the future, SL can be used to train distributed AI models for any histopathology image analysis task, eliminating the need for data transfer.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35469069      PMCID: PMC9205774          DOI: 10.1038/s41591-022-01768-5

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   87.241


  39 in total

1.  Development of AI-based pathology biomarkers in gastrointestinal and liver cancer.

Authors:  Jakob N Kather; Julien Calderaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10       Impact factor: 46.802

Review 2.  Designing deep learning studies in cancer diagnostics.

Authors:  Andreas Kleppe; Ole-Johan Skrede; Sepp De Raedt; Knut Liestøl; David J Kerr; Håvard E Danielsen
Journal:  Nat Rev Cancer       Date:  2021-01-29       Impact factor: 60.716

3.  Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.

Authors:  Jakob Nikolas Kather; Alexander T Pearson; Niels Halama; Dirk Jäger; Jeremias Krause; Sven H Loosen; Alexander Marx; Peter Boor; Frank Tacke; Ulf Peter Neumann; Heike I Grabsch; Takaki Yoshikawa; Hermann Brenner; Jenny Chang-Claude; Michael Hoffmeister; Christian Trautwein; Tom Luedde
Journal:  Nat Med       Date:  2019-06-03       Impact factor: 53.440

4.  AI-based pathology predicts origins for cancers of unknown primary.

Authors:  Tiffany Y Chen; Drew F K Williamson; Ming Y Lu; Melissa Zhao; Maha Shady; Jana Lipkova; Faisal Mahmood
Journal:  Nature       Date:  2021-05-05       Impact factor: 49.962

5.  Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis.

Authors:  Yu Fu; Alexander W Jung; Ramon Viñas Torne; Santiago Gonzalez; Harald Vöhringer; Artem Shmatko; Lucy R Yates; Mercedes Jimenez-Linan; Luiza Moore; Moritz Gerstung
Journal:  Nat Cancer       Date:  2020-07-27

6.  Artificial intelligence in cancer research, diagnosis and therapy.

Authors:  Olivier Elemento; Christina Leslie; Johan Lundin; Georgia Tourassi
Journal:  Nat Rev Cancer       Date:  2021-09-17       Impact factor: 60.716

Review 7.  Harnessing multimodal data integration to advance precision oncology.

Authors:  Kevin M Boehm; Pegah Khosravi; Rami Vanguri; Jianjiong Gao; Sohrab P Shah
Journal:  Nat Rev Cancer       Date:  2021-10-18       Impact factor: 69.800

8.  The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database.

Authors:  Stan Benjamens; Pranavsingh Dhunnoo; Bertalan Meskó
Journal:  NPJ Digit Med       Date:  2020-09-11

9.  Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.

Authors:  Nicolas Coudray; Paolo Santiago Ocampo; Theodore Sakellaropoulos; Navneet Narula; Matija Snuderl; David Fenyö; Andre L Moreira; Narges Razavian; Aristotelis Tsirigos
Journal:  Nat Med       Date:  2018-09-17       Impact factor: 53.440

Review 10.  Deep learning in cancer pathology: a new generation of clinical biomarkers.

Authors:  Amelie Echle; Niklas Timon Rindtorff; Titus Josef Brinker; Tom Luedde; Alexander Thomas Pearson; Jakob Nikolas Kather
Journal:  Br J Cancer       Date:  2020-11-18       Impact factor: 7.640

View more
  3 in total

1.  Artificial intelligence in Barrett's oesophagus and the need for shared and combined data.

Authors:  Rüdiger Schmitz; Jakob Nikolas Kather
Journal:  United European Gastroenterol J       Date:  2022-06-15       Impact factor: 6.866

2.  Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning.

Authors:  Oliver Lester Saldanha; Hannah Sophie Muti; Heike I Grabsch; Rupert Langer; Bastian Dislich; Meike Kohlruss; Gisela Keller; Marko van Treeck; Katherine Jane Hewitt; Fiona R Kolbinger; Gregory Patrick Veldhuizen; Peter Boor; Sebastian Foersch; Daniel Truhn; Jakob Nikolas Kather
Journal:  Gastric Cancer       Date:  2022-10-20       Impact factor: 7.701

3.  When blockchain meets artificial intelligence: An application to cancer histopathology.

Authors:  Runyu Hong; David Fenyö
Journal:  Cell Rep Med       Date:  2022-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.